Should patients with localized prostate cancer receive primary androgen deprivation therapy?: Commentary

Nature Clinical Practice Urology

Volumn 5, Issue 12, 2008, Pages 648-649

  Namiki, Mikio ^a   Mizokami, Atsushi ^a   Akaza, Hideyuki ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURVIVAL; CANCER THERAPY; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DECISION MAKING; HUMAN; INTERVENTION STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIMARY ANDROGEN DEPRIVATION THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SHORT SURVEY; TREATMENT INDICATION;

EID: 57449105245     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1233     Document Type: Short Survey

References (8)

1. Lu-Yao GL et al. (2008) Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA 300: 173-181
2. Cancer Registration Committee of the Japanese Urological Association (2005) Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol 12: 46-61
3. Meng MV et al. (2003) Predictors of treatment after initial surveillance in men with prostate cancer: Results from CaPSURE. J Urol 170: 2279-2283
4. Kitagawa Y et al. (2003) Pathological effects of neoadjuvant hormonal therapy help predict progression of prostate cancer after radical prostatectomy. Int J Urol 10: 377-382
5. Labrie F et al. (2002) Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer? Urology 60: 115-119
6. Ueno S et al. (2006) Efficacy of primary hormonal therapy for patients with localized and locally advanced prostate cancer: A retrospective multicenter study. Int J Urol 13: 1494-1500
7. Wilt TJ et al. (2008) Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148: 435-448
8. Hoffman RM et al. (2003) Patient satisfaction with treatment decisions for clinically localized prostate carcinoma: Results from the Prostate Cancer Outcomes Study. Cancer 97: 1653-1662